Home

Intelligence

Services

Subscriptions

News

About Us

Sign In

 

Document Preview

Registration Rights Agreement

 

Click "Add to Cart" button to purchase document. 
Documents are emailed immediately after purchase. 
You can also browse documents by
title, category, or company... or click here for help finding documents.

 

Title:

Registration Rights Agreement

Entities:

Novartis Pharma AG; Oravax Inc; Dewey Ballantine LLP; Kramer Levin Naftalis & Frankel, LLP

Date:

2001

Size:

Preview shows 5KB of 59KB total

Price:

$40

ID:

#1408148

 

 

► Corporate ► Rights ► Registration Rights Agreements
► Services ► Legal
► Biotech & Drugs ► Pharmaceutical Preparations

 

 

Start of Preview


                         REGISTRATION RIGHTS AGREEMENT


THIS REGISTRATION RIGHTS AGREEMENT (this "Agreement") is made and entered
into as of September 28, 2001, between Organogenesis, Inc., a corporation
organized and existing under the laws of the State of Delaware (the "Company"),
and Novartis Pharma AG, a corporation organized under the laws of Switzerland
("Novartis", or individually and with its permitted successors and assigns, the
"Investor"). This Agreement is made pursuant to the Securities Purchase
Agreement, dated as February 23, 2001 among the Company and the Investor (the
"Securities Purchase Agreement"). Capitalized terms used herein and not
otherwise defined herein shall have the respective meanings set forth in the
Securities Purchase Agreement.

WHEREAS, in order to induce the Company to enter into the Securities
Purchase Agreement and to induce the Investor to invest funds in the Company
pursuant to the Securities Purchase Agreement, the Investor and the Company
hereby agree that this Agreement shall govern the rights of the Investor to
cause the Company to register for resale the shares of Common Stock issuable to
the Investor and certain other matters as set forth herein:

NOW, THEREFORE, the parties hereto mutually agree as follows:

SECTION 1. DEFINITIONS. As used in this Agreement, the following terms
shall have the following meanings:

"Advice" shall have the meaning set forth in Section 3.

"Affiliate" means, with respect to any Person, any other Person that
directly or indirectly controls or is controlled by or under common control with
such Person. For the purposes of this definition, "Control," when used with
respect to any Person, means the possession, direct or indirect, of the power to
direct or cause the direction of the management and policies of such Person,
whether through the ownership of voting securities, by contract or otherwise;
and the terms of "Affiliated," "Controlling" and "Controlled" have meanings
correlative to the foregoing.

"Business Day" shall mean any day, other than a Saturday, Sunday or one on
which banks are authorized by law to close in New York, New York.

"Closing(s)" shall have the meaning set forth in the Securities Purchase
Agreement.

"Closing Date(s)" shall have the meaning set forth in the Securities
Purchase Agreement.

"Commission" means the Securities and Exchange Commission.

"Common Stock" means the Company's Common Stock, par value $.01 per share,
and any other common equities issued by the Company, and any other shares of
stock issued or issuable with respect thereto (whether by way of a stock
dividend or stock split or in exchange for or in replacement of such shares or
otherwise in connection with a combination of shares, recapitalization, merger,
consolidation or other corporate reorganization).
<PAGE>

"Effectiveness Date" means the forty-fifth (45th) day following the
applicable Filing Date.

"Effectiveness Period" shall have the meaning set forth in Section 2(a).

"Exchange Act" means the Securities Exchange Act of 1934, as amended.

"Filing Date" means the tenth Business Day following any Closing Date if
the Resale Registration Statement is not effective as of such Closing Date;
provided, that, if the Resale Registration Statement is effective as of any
Closing and subsequently the effectiveness of such Resale Registration Statement
is suspended or otherwise withdrawn or limited by the Commission, the Filing
Date shall mean the tenth Business Day following such action by the Commission.

"Holder" or "Holders" means the holder or holders, as the case may be, from
time to time of Registrable Securities including, without limitation, the
Investor.

"Indemnified Party" shall have the meaning set forth in Section 5(c).

"Indemnifying Party" shall have the meaning set forth in Section 5(c).

"Investor" has the meaning specified in the Introduction to this Agreement.

"Losses" shall have the meaning set forth in Section 5(a).

"Person" means an individual or a corporation, partnership, trust,
incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or political subdivision
thereof) or other entity of any kind.

"Proceeding" means an action, claim, suit, investigation or proceeding

 

End of Preview

 

Home        Intelligence        Services        Subscriptions        News        About Us

Contact Us       Terms of Use       Resend Documents       Shopping Cart

Copyright © 2008 The Consus Group LLC